ARCHIVES

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

This article is from The Cancer Letter archive.

Vol. 33 No. 23 | June 15, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

Carroll Named Deputy Director At Huntsman; Pamer Leads Infectious Disease Service, MSKCC.

September 29, 2000

NCI Seeks Applications For Small Business Research Awards

February 28, 1997

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987